Atezolizumab in Combination with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients with Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer(Bio-Marker Lab Clinical Research)
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
February 2, 2018
End Date
February 1, 2022
Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Start Date
February 2, 2018
End Date
February 1, 2022